PFEB.F PFIZER INC.CDR REG.S

Healthcare Pharmaceuticals Frankfurt Exchange
8.05 EUR
Close of Nov 12, 2026
5.42 8.38
Market cap
EUR 135B
P/E
40.3x
P/B
1.70x
ROE
8.5%
Dividend yield
5.97%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is PFEB.F undervalued?

Graham number
Price8.05
Graham value4.62
Premium74.2%

PFEB.F trades 74.2% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

PFIZER INC.CDR REG.S fundamental analysis

No fundamental analysis for PFIZER INC.CDR REG.S yet.

PFIZER INC.CDR REG.S stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About PFIZER INC.CDR REG.S

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, …

Full company profile